Devices for ambulatory and home monitoring of blood pressure, lipids, coagulation, and weight management, part 2

American Journal of Health-System Pharmacy

Volumn 62, Issue 18, 2005, Pages 1894-1903

  Scolaro, Kelly L ^a,b   Stamm, Pamela L ^c   Lloyd, Kimberly Braxton ^c  

^a University of Florida ^*

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c AUBURN UNIVERSITY   (United States)

Author keywords

Ambulatory care; Anticoagulants; Blood pressure; Cholesterol; Devices; Economics; Home tests; Pharmaceutical services; Pharmacists; Reimbursement; Tests; Weight

Indexed keywords

AMBULATORY MONITORING; BLOOD CLOTTING; BLOOD PRESSURE MONITORING; BODY COMPOSITION; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; HEALTH CARE; HEALTH CARE COST; HEART RATE; HOME MONITORING; IMPEDANCE; LIPID BLOOD LEVEL; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 24944469810     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp040346.p2     Document Type: Review

References (60)

1. Hull R, Hirsh J, Jay R et al. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J. Med. 1982; 307:1676-81.
2. Hirsh J, Fuster V, Ansell J et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol. 2003; 41:1633-52.
3. Chapman DC, Stephens MA, Hamann GL et al. Accuracy, clinical correlation, and patient acceptance of two handheld prothrombin time monitoring devices in the ambulatory setting. Ann Pharmacother. 1999; 33:775-80.
4. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998; 158:1641-7.
5. Beyth RJ, Landefeld CS. Prevention of major bleeding in older patients treated with warfarin: results of a randomized trial. J Gen Intern Med. 1997; 12:66. Abstract.
6. Horstkotte D, Piper C, Wiemer M et al. Improvement of prognosis by home prothrombin estimation in patients with life-long anticoagulant therapy. Eur Heart J. 1996; 17(suppl):230. Abstract.
7. Kortke H, Korfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg. 2001; 72:44-8.
8. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. JAMA. 1999; 281:145-50.
9. Ansell JE, Patel N, Ostrovsky D et al. Long-term patient self-management of oral anticoagulation. Arch Intern Med. 1995; 155:2185-9.
10. Watzke HH, Forberg E, Svolba G et al. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost. 2000; 83:661-5.
11. Cromheecke ME, Levi M, Colly LP et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomized cross-over comparison. Lancet. 2000; 356:97-102.
12. Centers for Medicare and Medicaid Services. Center for National Coverage Determinations (NCDs) home prothrombin time International Normalized Ratio (INR) monitoring for anticoagulation management. www.cms.hhs.gov/mcd/ viewlmrp-id=13372&lmrp_ version= 2&show=all (accessed 2004 Jul 7).
13. Fitzmaurice DA, Machin SJ; British Society of Haematology Task Force for Haemostasis and Thrombosis. Recommendations for patients undertaking self management of oral anticoagulation. BMJ. 2001; 323:985-9.
14. Van den Besselaar AM. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis. 2001; 12:35-40.
15. Avocet Medical. Avocet PT System. www.avocetmedical.com (accessed 2004 Jun 22).
16. PointofCare.net. Avocet Medical. www.pointofcare.net/vendors/ avocet.htm (accessed 2004 Jun 22).
17. Roche Diagnostics, Inc. 510(k) premarket application, www.accessdata.fda.gov/ scripts/cdrh/cfdocs/cfClia/Search.cfm (accessed 2004 Jul 3).
18. Diavant. CoaguChek System Meter. www.diavant.us (accessed 2004 Jun 22).
19. Diavant. CoaguChek S System Meter. www.diavant.us/diavant/ CMSFront.html?pgid=3,1,7,0 (accessed 2004 Jun 22).
20. Lifescan. Harmony INR test strips. www.harmonyinr.com (accessed 2004 Jun 22).
21. International Technodyne Corporation. Prothrombin time whole blood test: NCCLS formatted procedure. www. itcmed.com/protime_nccls.pdf (accessed 2004 Jun 22).
22. HemoSense. The INRatio meter. www.hemosense.com/product/ product_index.html (accessed 2004 Jun 22).
23. Data on file: Technical Report 0102. IN-Ratio test strip shelf life. HemoSense, San Jose, CA; 2004 May.
24. International Technodyne Corporation. ProTime Microcoagulation System. www.itcmed.com/protime.shtml (accessed 2004 Jun 22).
25. Tritschler W, Zerback R, Plesch W et al. Coagulation-optimized control of anticoagulation therapy with the CoaguChek S System: results of performance assessments and user evaluations. 1st ed. Mannheim, Germany: Roche Diagnostics GmbH; 2001:6,14-9.
26. Groce JB III, Carter BL. Hematology: blood coagulation tests. In: Traub S, ed. Basic skills in interpreting laboratory data. 2nd ed. Bethesda, MD: American Society of Health-System Pharmacists; 1996:321-46.
27. Carrasco C, Campbell B, Shiach C. Effects of the lupus anticoagulant on the control of oral anticoagulant treatment. Br J Haematol. 2004; 124:562-3.
28. Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med. 1997; 127:177-8.
29. National Institute of Diabetes and Digestive and Kidney Diseases. Statistics related to overweight and obesity. http:// win.niddk.nih.gov/ statistics/index.htm (accessed 2004 Jul 7).
30. National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. www.nhlbi.nih.gov/guidelines/obesity/ ob_gdlns.pdf (accessed 2004 Jul 5).
31. Brodie D, Moscrip V, Hutcheon R. Body composition measurement: a review of hydrodensitometry, anthrompometry, and impedence methods. Nutrition. 1998; 14:296-310.
32. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged 16 to 72 years. Br J Nutr. 1974; 32:77-97.
33. Brodie DA. Techniques of measurement of body composition. Part I. Sports Med. 1988;5:11-40.
34. Heyward VH, Wagner D. Applied body composition assessment. 2nd ed. Champaign, IL: Human Kinetics; 2004.
35. National Institutes of Health. Bioelectrical impedance analysis in body composition measurement. http://consensus. nih.gov/ta/015/015_intro.htm (accessed 2004 Jul 8).
36. Tanita. Body composition analyzer/ scales. www.tanita.com/ BodyComposition. shtml (accessed 2004 Jul 9).
37. Futrex. Body composition analyzers. www.futrex.com (accessed 2004 Jul 9).
38. Ellis KJ. Selected body composition methods can be used in field studies. J Nutr. 2001; 131:15898-958.
39. Life Measurements. BOD POD. www.bodpod.com (accessed 2004 Jul 8).
40. American Heart Association. Guidelines for weight management programs for healthy adults. www.americanheart.org/ presenter.jhtml?identifier=1226 (accessed 2004 Jul 5).
41. National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-executive summary. www.nhlbi.nih.gov/ guidelines/obesity/sum_clin.htm (accessed 2004 Jul 5).
42. American College of Sports Medicine position stand: the recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc. 1998; 30:975-91.
43. Hackenmiller C. Goal achievement measured by heart. www/polarusa.com/ news/shownews.asp?ArticleID=149 (accessed 2004 Jul 5).
44. Achten J, Jeukendrup AE. Heart rate monitoring: applications and limitations. Sports Med. 2003; 33:517-38.
45. Waehner P. Top 5 heart rate monitors. www.exercise.about.com/cs/toppicks/ tp/HRM.htm (accessed 2004 Jul 5).
46. Drugstore.com. Heart rate monitors. www.drugstore.com (accessed 2004 Jul 5).
47. Macfarlane DJ, Fogarty B, Hopkins WG. The accuracy and variability of commercially available heart rate monitors. N Z J Sports Med. 1989; 17:51-3.
48. Ruha A, Sallinen S, Nissila S. A real-time microprocessor QRS detector system with a 1-ms timing accuracy for the measurement of ambulatory HRV. IEEE Trans Biomed Eng. 1997; 44:159-67.
49. Kikuya M, Hozawa A, Ohokubo T et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension. 2000; 36:901-6.
50. Palatini P, Thijs L, Staessen JA et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med. 2002; 162:2313-21.
51. Tudor-Locke C, Williams JE, Reis JP et al. Utility of pedometers for assessing physical activity convergent validity. Sports Med. 2002; 32:795-808.
52. Moreau KL, Degarmo R, Langley J et al. Increasing daily walking lowers blood pressure in postmenopausal women. Med Sci Sports Exerc. 2001; 33:1825-31.
53. Swartz AM, Thompson DL. Increasing daily walking improves glucose tolerance in overweight women. Res Q Exerc Sport. 2002; 73(suppl):A61. Abstract.
54. Crouter SE, Schneider PL, Karabulut M et al. Validity of 10 electronic pedometers for measuring steps, distance, and energy cost. Med Sci Sports Exerc. 2003; 35:1455-60.
55. Schneider PL, Crouter SE, Bassett DR. Pedometer measures of free-living physical activity: comparison of 13 models. Med Sci Sports Exerc. 2004; 36:331-5.
56. Tudor-Locke C, Bassett DR Jr. How many steps/day are enough? Preliminary pedometer indices for public health. Sports Med. 2004; 34:1-8.
57. Tudor-Locke C, Jones R, Myers AM et al. Contribution of structured exercise class participation and informal walking for exercise to daily physical activity in community-dwelling older adults. Res Q Exerc Sport. 2002; 73:350-6.
58. Welk BE, Differding JA, Thompson RW et al. The utility of the Digi-walker step counter to assess daily physical activity patterns. Med Sci Sports Exerc. 2000; 32(9 suppl):S481-8.
59. Freedonia Group. Patient monitoring systems to 2008. www.freedoniagroup. com/Patient-Monitoring-Systems.html (accessed 2004 Jul 1).
60. Gutierres SL, Welty TE. Point-of-care testing: an introduction. Ann Pharmacother. 2004; 38:119-25.